ClinicalTrials.Veeva

Menu

Efficacy and Safety of Protein Product in Volunteers With Sarcopenia

C

Chulalongkorn University

Status

Not yet enrolling

Conditions

Sarcopenia

Treatments

Dietary Supplement: isolated soy protein
Dietary Supplement: whey protein isolate
Dietary Supplement: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05869305
IRBRTA 426/2566

Details and patient eligibility

About

The objective of this study are to evaluate efficacy and safety of protein product in volunteers with sarcopenia.

Full description

There are 45 patients in this study. They are randomly divided into 3 groups which are whey protein isolate group, isolated soy protein group, placebo group. They will take the sample 1 sachet/day for 12 weeks. Muscle strength, muscle mass, physical performance, sarcopenia score, body weight, body mass index, protein, immunoglobulins, quality of life, liver function, kidney function, other laboratory value, and adverse effects are evaluated.

Enrollment

45 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age more than 20 years
  • Sarcopenia score more than 4
  • Handgrip strength less than 28 kg in male and less than 18 kg in female and muscle mass less than 7 kg/m2 in male and less than 5.7 kg/m2 in female or Gait speed (6-meter walk) less than 1 m/s
  • Can take protein from animal
  • Can read and write or have people to look after
  • Willing to participate in this study

Exclusion criteria

  • Allergic to protein from animals and plants
  • Hepatitis or cirrhosis
  • Glomerular disease or glomerular filtration rate less than 60 ml/min/1.73m2
  • Cancer or heart disease
  • Cannot walk
  • Pregnancy and lactation
  • Duodenal surgery
  • Take protein supplement within 2 weeks
  • Take protein in normal food more than 1.2 g/body weight/day
  • Participating in other studies

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

45 participants in 3 patient groups

whey protein isolate group
Experimental group
Description:
Whey protein isolate is contained in the sachet.
Treatment:
Dietary Supplement: whey protein isolate
isolated soy protein group
Experimental group
Description:
Isolated soy protein, pea protein isolate, and brown rice protein are contained in the sachet.
Treatment:
Dietary Supplement: isolated soy protein
placebo group
Experimental group
Description:
Base powder without proteins is contained in the sachet
Treatment:
Dietary Supplement: placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems